Digital Pathology Interview | Tissuepathology.com

From the Proscia Blog: Q&A: Engineering Excellence—How Concentriq LS Delivers a New Standard for Enterprise-Scale Performance

Erica Goodpaster — Tue, 13 May 2025 13:01:35 +0000

As life sciences R&D teams increasingly leverage digital pathology and AI to accelerate their precision medicine programs, Proscia’s Concentriq LS platform is handling unprecedented volumes of high-resolution images, complex annotations, and collaborative workflows. With the latest release, our engineering team has made significant strides in performance. I sat down with Taylor Tignino, Senior Software Engineer […]

The post From the Proscia Blog: Q&A: Engineering Excellence—How Concentriq LS Delivers a New Standard for Enterprise-Scale Performance first appeared on Tissuepathology.com.

Deep Bio and PathAI Collaborate to Drive AI-Powered Innovations in Digital Pathology

Erica Goodpaster — Fri, 22 Nov 2024 12:08:09 +0000

Deep Bio: Integrating Deep Bio’s DeepDx Prostate Algorithm into PathAI’s AISight IMS Platform SEOUL, SOUTH KOREA, November 19, 2024 /EINPresswire.com/ — Deep Bio, a leader in artificial intelligence for digital pathology, announced a collaboration to integrate its prostate cancer analysis solution, DeepDx Prostate, with PathAI’s AISight®1 Image Management System (IMS). This collaboration combines Deep Bio’s clinically […]

The post Deep Bio and PathAI Collaborate to Drive AI-Powered Innovations in Digital Pathology first appeared on Tissuepathology.com.

Aiosyn: Diana Rosentul explains the complexities of regulatory compliance for integrating AI-based solutions in the healthcare industry

Erica Goodpaster — Wed, 07 Feb 2024 12:33:26 +0000

From Aiosyn blog: Diana Rosentul, a Regulatory Affairs Specialist at Aiosyn, intricately manages the regulatory landscape associated with the integration of AI-based solutions within clinical and research institutions. Drawing upon her extensive background in Medical Sciences and the regulation of Medical Devices, Diana discusses challenges linked to staying up-to-date and shares her insights on handling […]

The post Aiosyn: Diana Rosentul explains the complexities of regulatory compliance for integrating AI-based solutions in the healthcare industry first appeared on Tissuepathology.com.

Validation of PD-L1 AI model launches in six labs across the Netherlands

Dr. Keith J. Kaplan — Mon, 22 Mar 2021 13:05:41 +0000

Labs in the Netherlands are joining together to launch an AI model validation study for PD-L1 scoring with a goal of multi-source domain adaptation. Introduction Programmed death-ligand 1 (PDL1) is a protein that, when attached to T cells, prevent the immune system from killing cancer cells. Hence, PDL1 is used as a biomarker for tumor […]

The post Validation of PD-L1 AI model launches in six labs across the Netherlands first appeared on Tissuepathology.com.